• home
  • contact
  • join us
About Us
  • Disease areas and clinical needs
  • Market Growth
  • Patient Advocacy Links

Chronic diseases such as Alzheimer's disease, Parkinson's disease, Dementia with Lewy bodies and Diabetes Mellitus affect tens of millions of people worldwide. Our goal is to develop novel molecular imaging agents that allow the detection of the earliest stages of these diseases, before clinical symptoms develop.